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of 5 mm3 the runtime of the reconstruction was about two 
days on a cluster.  
 
 
 
Figure 1: Dose (left), γ-ray emissions (center), and 
reconstructed image (right) for the simulated patient case. 
 
Conclusions: By means of Geant4, an end-to-end test was 
performed which models clinical conditions. The impact of 
various parameters on the applicability of the Compton 
camera was evaluated. The reconstruction algorithm still has 
potential for improvements with respect to performance. 
Furthermore, in practice, the costs and the complexity of a 
Compton camera system could lead to the preference of 
simpler methods of PGI.  
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Radiotherapy (RT) research studies operate with vast 
amounts of imaging and planning data. A purpose-built 
electronic data processing system helps to eliminate errors, 
prevent data losses and achieve high data quality. This work 
presents methods and tools used in data processing pipeline 
for the VoxTox study. 
The study will include over 1000 patient data sets comprised 
of TomoTherapy® imaging and planning data. Data is 
collected at hospital site, anonymised, tested and 
transferred to Cavendish Laboratory for processing and 
storage.  
A pseudo-anonymisation system was designed, in which each 
patient identifier was substituted by a token that can be 
decrypted at the hospital site to re-identify the patient. A 
token is auto-generated upon adding patient details to the 
study master file and saved in a dedicated database.  
Patient imaging and planning data are extracted and 
converted to Digital Imaging and Communications in Medicine 
(DICOM) format by in-house developed software. The 
software tokenises data on-the-fly and makes use of DICOM 
private tags to add auxiliary data.  
Testing is performed before and after transfer between sites 
using MD5 hashes and file lists. As the time gap between RT 
completion and data collection is small, missing data are 
identified early and can be recovered.  
Daily doses are calculated using a modification of CheckTomo 
application distributed on a computer cluster with 228 job 
slots via GANGA job management tool originally developed 
for ATLAS project. 
The images are outlined using purpose-built Matlab software 
based on Chan-Vese segmentation algorithm. Both tools are 
user-interface (UI) free and configurable via text input files 
that can be auto-generated. Root framework is used for data 
analysis and visualisation. 
Toxicity data is collected in the clinic using MOSAIQ® 
oncology information system and collated with the patient 
reported outcomes in KeyPoint® software. The electronic-
only data acquisition guarantees consistency of format and 
freedom from transcription errors. 
On average, VoxTox toolkit outperforms conventional tools 
used in the clinic by factor 6 (Table 1). Data retrieval is 
conventionally done via UI on TomoTherapy planning station. 
There is no tool to obtain TomoTherapy daily doses. 
Conventional contouring is performed by an experienced 
oncologist. Toxicity questionnaires are usually entered on 
paper forms and transcribed to electronic documents. 
Conventional data testing is a manual check of all files and 
folders in patient data set. 
 
 
 
We created a system that is modular, robust and efficient. 
All processing tools can run on a single computer or be 
deployed in a job management system on a cluster. 
Utilization of existing tools and staff skills minimizes project 
costs and accelerates the development. Key design elements 
such as pseudo-anonymisation, text-based inputs, batch 
processing and electronic data entry can be applied to any RT 
study. 
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Purpose: In proton therapy a generic relative biological 
effectiveness (RBE) of 1.1 has traditionally been clinically 
applied, implying that protons are slightly more effective 
than photons. However, there exist large amounts of data, 
mainly from in vitro studies, demonstrating that the RBE is 
variable and dependent on a set of factors, including the 
radiation quality of the beam. Most of the phenomenological 
models made for estimating the RBE use the dose average 
Linear Energy Transfer (LETd) as a parameter for the 
radiation quality. However, such a simplified description of 
the quality might lead to inaccurate RBE. In this work a new 
RBE model for proton therapy has been developed, utilizing 
the dose weighted LET spectrum (d(L)) to describe the 
radiation quality.  
Materials/methods: A new formalism for RBE calculation is 
introduced, based on the concept of RBEmax and the usage of 
biological weighting functions. RBEmax is found by weighting 
the LET spectrum by rmax(L), a smooth continuous function for 
the full LET range of protons (0-83 keV/μm). We assumed 
that rmax(L) is nonlinear and symmetric around a turnover 
point (LETu). A quantitative description of rmax(L) was found 
by making a regression fit to the α/αx of 96 data points, 
where the α and αx are coefficients of the linear-quadratic 
model, for proton and photon irradiation respectively. These 
points were extracted from experiments with semi-
monoenergetic proton beams found in literature. In our 
model we have assumed that β = βx and thus RBEmin = 1. A 
Fluka Monte Carlo simulation was done to check the new 
calculation method was benchmarked against a constant RBE 
of 1.1 and an existing LETd based model for variable RBE 
(McNamara et al., 2015). 
Results: By fitting rmax(L) to the data, we found a peak at 
LETu=34.5 keV/μm. The fit had a R2 value of 0.634. In the 
simulated example, the new model estimated a RBE of 1.00-
1.02 in the entrance region. The RBE rises from 1.05 to 1.6 
along the SOBP. This indicates that a constant RBE of 1.1 
leads to an overestimate of the dose to the normal tissue, as 
well to the proximal part of the tumour. Compared to the 
LETd based model, the RBE is approximately 9-11% lower at 
all depths.  
Conclusions: A dose and tissue dependent RBE model, based 
on the LET spectrum has been developed for application in 
proton therapy. Compared to LETd–based model, this 
approach might give a better estimation of the biological 
dose in a mixed radiation field. The model could be further 
optimized, by adjusting the definition of rmax(L) and 
introducing a term for rmin(L), taking into account a variable 
LET dependent β parameter. 
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Purpose: The growing interest in charged particle therapy 
has led to the development of dedicated systems able to 
monitor the dose delivered to the patient. Positron Emission 
Tomography (PET) is a non-invasive way for in-vivo 
verification of the dose delivery. In fact, during particle 
irradiation, various ß
+
-emitting isotopes (15O, 11C etc.) are 
generated in the patient and this activity distribution can be 
related to the delivered dose. 
Materials/methods: A compact PET system was developed to 
be installed close to the patient. The PET system, DoPET, is 
based on two planar heads. Over the years the dimension of 
the heads was increased, from 5cm x 5cm, to 10cm x10cm 
and finally to the dimension of 15cm x 15cm per head. The 
heads result from the assembly of several detecting 
modules: in the present prototype there are 9 modules (3x3) 
per head. Each detecting module, (5cm x 5cm) consists of 
a segmented LYSO crystal matrix (2 mm pitch) coupled to a 
PSPMT. The readout is performed by custom electronics, and 
the data acquisition was designed to cope with the high 
fluxes present during the treatment plan (TP) delivery. The 
data reconstruction of the measured 3-D ß
+
-activity 
distribution, based on a MLEM-OSEM 3D algorithm takes less 
than one minute. 
The system was mostly characterized for proton therapy 
applications: at CATANA, a cyclotron-based center(LNS-
INFN Catania, Italy), and at CNAO a synchrotron-based 
center (Pavia, Italy). Preliminary characterization for 
carbon irradiations were also performed. 
Results: The DoPET spatial resolution guarantees the 
reconstruction of the distal fall activity profile with a 
sensibility of 1 mm, operating in-treatment [1, 2]. The in-
treatment data were useful. In fact, DoPET provided 
information on a whole protonTP and on its very early 
phases [3]. A study was done delivering only the proton TP 
Highest Energy Layer: thanks to the sharp shape of the 
mono-energetic activity fall- off profile, the shift due to 
the presence of a small air cavity was evident. 
The experimental ß
+
-activity profiles were also compared to 
calculated data obtained with FLUKA Monte Carlo, with very 
satisfactory agreement [3]. 
Conclusions: DoPET represents a reliable and fast in-
treatment monitoring system that could act as an image 
guidance in the case of hypo-fractionation scheme. The 
present head dimension allows studies with anthropomorphic 
phantoms that will be done before moving onto patients. 
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